IP Library › Granted Patent US 8,748,657
Granted Patent B2
US 8,748,657 · App. 13/910,583 · Granted Jun 10, 2014

Process to prepare treprostinil

Inventors: Hitesh Batra (Herndon, VA); Sudersan M. Tuladhar (Silver Spring, MD); Raju Penmasta (Herndon, VA); David A. Walsh (Palmyra, VA)
Assignee: United Therapeutics Corporation
C07C51/08C07C51/41C07D59/60C07C59/72C07C405/0075C07C39/12C07C39/17A01N37/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,748,657
App. No.
13/910,583
Granted
Jun 10, 2014
Kind
B2
Abstract

This present invention relates to an improved process to prepare prostacyclin derivatives. One embodiment provides for an improved process to convert benzindene triol to treprostinil via salts of treprostinil and to purify treprostinil.

Claims (7)

1. A process for producing a pharmaceutical composition comprising treprostinil, comprising providing a starting batch of treprostinil having one or more impurities resulting from prior alkylation and hydrolysis steps, forming a salt of treprostinil by combining the starting batch and a base, isolating the treprostinil salt, and preparing a pharmaceutical solution from the isolated salt comprising treprostinil or a pharmaceutically acceptable salt thereof from the isolated treprostinil salt, whereby a level of one or more impurities found in the starting batch of treprostinil is lower in the pharmaceutical composition, and wherein said alkylation is alkylation of benzindene triol.

2. The process of claim 1 , wherein the salt is isolated in crystalline form.

3. The process of claim 2 , wherein the isolated salt is at least 99.8% pure.

4. The process of claim 1 , wherein the base is selected from the group consisting of sodium, ammonia, potassium, calcium, ethanolamine, diethanolamine, N-methylglucamine, and choline.

5. The process of claim 4 , wherein the base is diethanolamine.

6. The process of claim 1 , wherein the base is combined with treprostinil that has not been previously isolated.

7. The process of claim 1 , wherein the isolated salt is stored at ambient temperature.

Continuity (4)
Continuation 13548446 · Jul 13, 2012
Continuation 12334731 · Dec 15, 2008
Provisional Application 61014232 · Dec 17, 2007
Related Publication 20130267734A1 · Oct 10, 2013